NCT02485600
Brief summary
This is an open-label, postmarketing, observational study to document health outcomes, in Canadian patients with advanced Parkinson's disease and long-term treatment with an active drug (active drug intestinal gel).
Observational study
Age:
From 18 Years to 99 Years.
Inclusion Criteria:
- Diagnosed with advanced Parkinson's Disease
- Prescribed Duodopa by his/her treating physician.
Exclusion Criteria:
- Patients who were previously treated with Duodopa.
- Presence of other condition that, in the opinion of the treating physician, prohibits
the patient from participating in the study or obscures the assessment of the
treatment of advanced PD.